Moody’s assigns ‘A1’ rating to John Muir Health’s bonds

Moody’s Investors Service has assigned an “A1” rating to Walnut Creek, Calif.-based John Muir Health’s proposed series 2016 bonds, affecting up to $235 million.

Advertisement

The rating assignment reflects the system’s large size, solid market position and excellent reputation in a competitive area.

Moody’s also affirmed the “A1” rating on approximately $390 million of John Muir Health’s outstanding debt.

More articles on healthcare finance:
VA mistakenly ends benefits for living veterans, believing them to be dead
Mount Sinai to shutter Beth Israel hospital
Houston pharmaceutical company files for $12M IPO: 4 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.